nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—CYP3A4—Imiquimod—skin cancer	0.176	0.292	CbGbCtD
Salbutamol—CYP3A4—Temozolomide—skin cancer	0.176	0.292	CbGbCtD
Salbutamol—CYP3A4—Vismodegib—skin cancer	0.122	0.202	CbGbCtD
Salbutamol—CYP3A4—Vemurafenib—skin cancer	0.0964	0.16	CbGbCtD
Salbutamol—CYP3A4—Docetaxel—skin cancer	0.0331	0.0548	CbGbCtD
Salbutamol—Conjunctivitis—Fluorouracil—skin cancer	0.000688	0.00173	CcSEcCtD
Salbutamol—Asthenia—Vemurafenib—skin cancer	0.000688	0.00173	CcSEcCtD
Salbutamol—Hypoaesthesia—Temozolomide—skin cancer	0.000686	0.00173	CcSEcCtD
Salbutamol—Pharyngitis—Temozolomide—skin cancer	0.000684	0.00173	CcSEcCtD
Salbutamol—Chills—Dactinomycin—skin cancer	0.000684	0.00173	CcSEcCtD
Salbutamol—Urinary tract disorder—Temozolomide—skin cancer	0.000681	0.00172	CcSEcCtD
Salbutamol—Pruritus—Vemurafenib—skin cancer	0.000678	0.00171	CcSEcCtD
Salbutamol—Connective tissue disorder—Temozolomide—skin cancer	0.000678	0.00171	CcSEcCtD
Salbutamol—Urethral disorder—Temozolomide—skin cancer	0.000676	0.0017	CcSEcCtD
Salbutamol—Feeling abnormal—Imiquimod—skin cancer	0.000674	0.0017	CcSEcCtD
Salbutamol—Gastrointestinal pain—Imiquimod—skin cancer	0.000669	0.00169	CcSEcCtD
Salbutamol—Epistaxis—Fluorouracil—skin cancer	0.000668	0.00168	CcSEcCtD
Salbutamol—Sinusitis—Fluorouracil—skin cancer	0.000664	0.00167	CcSEcCtD
Salbutamol—Ill-defined disorder—Bleomycin—skin cancer	0.00066	0.00167	CcSEcCtD
Salbutamol—Diarrhoea—Vemurafenib—skin cancer	0.000656	0.00165	CcSEcCtD
Salbutamol—Migraine—Docetaxel—skin cancer	0.000652	0.00165	CcSEcCtD
Salbutamol—Urticaria—Imiquimod—skin cancer	0.000649	0.00164	CcSEcCtD
Salbutamol—Abdominal pain—Imiquimod—skin cancer	0.000646	0.00163	CcSEcCtD
Salbutamol—Body temperature increased—Imiquimod—skin cancer	0.000646	0.00163	CcSEcCtD
Salbutamol—Tinnitus—Temozolomide—skin cancer	0.000643	0.00162	CcSEcCtD
Salbutamol—Malaise—Bleomycin—skin cancer	0.000642	0.00162	CcSEcCtD
Salbutamol—Flushing—Temozolomide—skin cancer	0.00064	0.00161	CcSEcCtD
Salbutamol—Cardiac disorder—Temozolomide—skin cancer	0.00064	0.00161	CcSEcCtD
Salbutamol—Haemoglobin—Fluorouracil—skin cancer	0.000639	0.00161	CcSEcCtD
Salbutamol—Rhinitis—Fluorouracil—skin cancer	0.000637	0.00161	CcSEcCtD
Salbutamol—Haemorrhage—Fluorouracil—skin cancer	0.000635	0.0016	CcSEcCtD
Salbutamol—Dizziness—Vemurafenib—skin cancer	0.000634	0.0016	CcSEcCtD
Salbutamol—Hypoaesthesia—Fluorouracil—skin cancer	0.000632	0.00159	CcSEcCtD
Salbutamol—Pharyngitis—Fluorouracil—skin cancer	0.000631	0.00159	CcSEcCtD
Salbutamol—Angiopathy—Temozolomide—skin cancer	0.000626	0.00158	CcSEcCtD
Salbutamol—Ataxia—Docetaxel—skin cancer	0.000623	0.00157	CcSEcCtD
Salbutamol—Immune system disorder—Temozolomide—skin cancer	0.000623	0.00157	CcSEcCtD
Salbutamol—Mediastinal disorder—Temozolomide—skin cancer	0.000621	0.00157	CcSEcCtD
Salbutamol—Cough—Bleomycin—skin cancer	0.000621	0.00157	CcSEcCtD
Salbutamol—Chills—Temozolomide—skin cancer	0.000619	0.00156	CcSEcCtD
Salbutamol—Ill-defined disorder—Dactinomycin—skin cancer	0.000616	0.00155	CcSEcCtD
Salbutamol—Vomiting—Vemurafenib—skin cancer	0.000609	0.00154	CcSEcCtD
Salbutamol—Chest pain—Bleomycin—skin cancer	0.000606	0.00153	CcSEcCtD
Salbutamol—Myalgia—Bleomycin—skin cancer	0.000606	0.00153	CcSEcCtD
Salbutamol—Abdominal pain upper—Docetaxel—skin cancer	0.000605	0.00153	CcSEcCtD
Salbutamol—Rash—Vemurafenib—skin cancer	0.000604	0.00152	CcSEcCtD
Salbutamol—Mental disorder—Temozolomide—skin cancer	0.000604	0.00152	CcSEcCtD
Salbutamol—Dermatitis—Vemurafenib—skin cancer	0.000604	0.00152	CcSEcCtD
Salbutamol—Hypersensitivity—Imiquimod—skin cancer	0.000602	0.00152	CcSEcCtD
Salbutamol—Headache—Vemurafenib—skin cancer	0.000601	0.00151	CcSEcCtD
Salbutamol—Malnutrition—Temozolomide—skin cancer	0.0006	0.00151	CcSEcCtD
Salbutamol—Discomfort—Bleomycin—skin cancer	0.000599	0.00151	CcSEcCtD
Salbutamol—Malaise—Dactinomycin—skin cancer	0.000599	0.00151	CcSEcCtD
Salbutamol—Cramp muscle—Docetaxel—skin cancer	0.000597	0.00151	CcSEcCtD
Salbutamol—Nasopharyngitis—Docetaxel—skin cancer	0.000593	0.00149	CcSEcCtD
Salbutamol—Dysgeusia—Temozolomide—skin cancer	0.000588	0.00148	CcSEcCtD
Salbutamol—Asthenia—Imiquimod—skin cancer	0.000587	0.00148	CcSEcCtD
Salbutamol—Anaphylactic shock—Bleomycin—skin cancer	0.000581	0.00146	CcSEcCtD
Salbutamol—Oedema—Bleomycin—skin cancer	0.000581	0.00146	CcSEcCtD
Salbutamol—Back pain—Temozolomide—skin cancer	0.000581	0.00146	CcSEcCtD
Salbutamol—Pruritus—Imiquimod—skin cancer	0.000578	0.00146	CcSEcCtD
Salbutamol—Infection—Bleomycin—skin cancer	0.000577	0.00146	CcSEcCtD
Salbutamol—Nausea—Vemurafenib—skin cancer	0.000569	0.00144	CcSEcCtD
Salbutamol—Arrhythmia—Fluorouracil—skin cancer	0.000568	0.00143	CcSEcCtD
Salbutamol—Myalgia—Dactinomycin—skin cancer	0.000565	0.00142	CcSEcCtD
Salbutamol—Bronchospasm—Docetaxel—skin cancer	0.000564	0.00142	CcSEcCtD
Salbutamol—Tremor—Temozolomide—skin cancer	0.000562	0.00142	CcSEcCtD
Salbutamol—Diarrhoea—Imiquimod—skin cancer	0.000559	0.00141	CcSEcCtD
Salbutamol—Discomfort—Dactinomycin—skin cancer	0.000558	0.00141	CcSEcCtD
Salbutamol—Angina pectoris—Docetaxel—skin cancer	0.000558	0.00141	CcSEcCtD
Salbutamol—Ill-defined disorder—Temozolomide—skin cancer	0.000557	0.0014	CcSEcCtD
Salbutamol—Anorexia—Bleomycin—skin cancer	0.000554	0.0014	CcSEcCtD
Salbutamol—Agitation—Temozolomide—skin cancer	0.000552	0.00139	CcSEcCtD
Salbutamol—Angioedema—Temozolomide—skin cancer	0.000549	0.00138	CcSEcCtD
Salbutamol—Hypotension—Bleomycin—skin cancer	0.000543	0.00137	CcSEcCtD
Salbutamol—Oedema—Dactinomycin—skin cancer	0.000542	0.00137	CcSEcCtD
Salbutamol—Malaise—Temozolomide—skin cancer	0.000541	0.00137	CcSEcCtD
Salbutamol—Dizziness—Imiquimod—skin cancer	0.000541	0.00136	CcSEcCtD
Salbutamol—Vertigo—Temozolomide—skin cancer	0.000539	0.00136	CcSEcCtD
Salbutamol—Infection—Dactinomycin—skin cancer	0.000538	0.00136	CcSEcCtD
Salbutamol—Palpitations—Temozolomide—skin cancer	0.00053	0.00134	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000529	0.00133	CcSEcCtD
Salbutamol—Cough—Temozolomide—skin cancer	0.000524	0.00132	CcSEcCtD
Salbutamol—Paraesthesia—Bleomycin—skin cancer	0.000522	0.00132	CcSEcCtD
Salbutamol—Vomiting—Imiquimod—skin cancer	0.00052	0.00131	CcSEcCtD
Salbutamol—Hypertension—Temozolomide—skin cancer	0.000518	0.00131	CcSEcCtD
Salbutamol—Dyspnoea—Bleomycin—skin cancer	0.000518	0.00131	CcSEcCtD
Salbutamol—Anorexia—Dactinomycin—skin cancer	0.000516	0.0013	CcSEcCtD
Salbutamol—Rash—Imiquimod—skin cancer	0.000515	0.0013	CcSEcCtD
Salbutamol—Dermatitis—Imiquimod—skin cancer	0.000515	0.0013	CcSEcCtD
Salbutamol—Headache—Imiquimod—skin cancer	0.000512	0.00129	CcSEcCtD
Salbutamol—Arthralgia—Temozolomide—skin cancer	0.000511	0.00129	CcSEcCtD
Salbutamol—Myalgia—Temozolomide—skin cancer	0.000511	0.00129	CcSEcCtD
Salbutamol—Anxiety—Temozolomide—skin cancer	0.000509	0.00128	CcSEcCtD
Salbutamol—Discomfort—Temozolomide—skin cancer	0.000505	0.00127	CcSEcCtD
Salbutamol—Decreased appetite—Bleomycin—skin cancer	0.000505	0.00127	CcSEcCtD
Salbutamol—Neuropathy peripheral—Docetaxel—skin cancer	0.000501	0.00126	CcSEcCtD
Salbutamol—Dry mouth—Temozolomide—skin cancer	0.0005	0.00126	CcSEcCtD
Salbutamol—Stomatitis—Docetaxel—skin cancer	0.000498	0.00126	CcSEcCtD
Salbutamol—Jaundice—Docetaxel—skin cancer	0.000498	0.00126	CcSEcCtD
Salbutamol—Pain—Bleomycin—skin cancer	0.000497	0.00125	CcSEcCtD
Salbutamol—Conjunctivitis—Docetaxel—skin cancer	0.000497	0.00125	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000493	0.00124	CcSEcCtD
Salbutamol—Oedema—Temozolomide—skin cancer	0.00049	0.00124	CcSEcCtD
Salbutamol—Anaphylactic shock—Temozolomide—skin cancer	0.00049	0.00124	CcSEcCtD
Salbutamol—Infection—Temozolomide—skin cancer	0.000487	0.00123	CcSEcCtD
Salbutamol—Nausea—Imiquimod—skin cancer	0.000486	0.00122	CcSEcCtD
Salbutamol—Epistaxis—Docetaxel—skin cancer	0.000482	0.00122	CcSEcCtD
Salbutamol—Nervous system disorder—Temozolomide—skin cancer	0.00048	0.00121	CcSEcCtD
Salbutamol—Feeling abnormal—Bleomycin—skin cancer	0.000479	0.00121	CcSEcCtD
Salbutamol—Skin disorder—Temozolomide—skin cancer	0.000476	0.0012	CcSEcCtD
Salbutamol—Hyperhidrosis—Temozolomide—skin cancer	0.000474	0.00119	CcSEcCtD
Salbutamol—Chest pain—Fluorouracil—skin cancer	0.000471	0.00119	CcSEcCtD
Salbutamol—Myalgia—Fluorouracil—skin cancer	0.000471	0.00119	CcSEcCtD
Salbutamol—Decreased appetite—Dactinomycin—skin cancer	0.000471	0.00119	CcSEcCtD
Salbutamol—Fatigue—Dactinomycin—skin cancer	0.000467	0.00118	CcSEcCtD
Salbutamol—Anorexia—Temozolomide—skin cancer	0.000467	0.00118	CcSEcCtD
Salbutamol—Discomfort—Fluorouracil—skin cancer	0.000465	0.00117	CcSEcCtD
Salbutamol—Pain—Dactinomycin—skin cancer	0.000463	0.00117	CcSEcCtD
Salbutamol—Urticaria—Bleomycin—skin cancer	0.000461	0.00116	CcSEcCtD
Salbutamol—Haemoglobin—Docetaxel—skin cancer	0.000461	0.00116	CcSEcCtD
Salbutamol—Rhinitis—Docetaxel—skin cancer	0.00046	0.00116	CcSEcCtD
Salbutamol—Body temperature increased—Bleomycin—skin cancer	0.000459	0.00116	CcSEcCtD
Salbutamol—Haemorrhage—Docetaxel—skin cancer	0.000459	0.00116	CcSEcCtD
Salbutamol—Hypoaesthesia—Docetaxel—skin cancer	0.000456	0.00115	CcSEcCtD
Salbutamol—Pharyngitis—Docetaxel—skin cancer	0.000455	0.00115	CcSEcCtD
Salbutamol—Urinary tract disorder—Docetaxel—skin cancer	0.000453	0.00114	CcSEcCtD
Salbutamol—Anaphylactic shock—Fluorouracil—skin cancer	0.000451	0.00114	CcSEcCtD
Salbutamol—Oedema—Fluorouracil—skin cancer	0.000451	0.00114	CcSEcCtD
Salbutamol—Connective tissue disorder—Docetaxel—skin cancer	0.000451	0.00114	CcSEcCtD
Salbutamol—Urethral disorder—Docetaxel—skin cancer	0.00045	0.00113	CcSEcCtD
Salbutamol—Infection—Fluorouracil—skin cancer	0.000448	0.00113	CcSEcCtD
Salbutamol—Feeling abnormal—Dactinomycin—skin cancer	0.000446	0.00113	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000446	0.00113	CcSEcCtD
Salbutamol—Insomnia—Temozolomide—skin cancer	0.000443	0.00112	CcSEcCtD
Salbutamol—Gastrointestinal pain—Dactinomycin—skin cancer	0.000443	0.00112	CcSEcCtD
Salbutamol—Nervous system disorder—Fluorouracil—skin cancer	0.000443	0.00112	CcSEcCtD
Salbutamol—Tachycardia—Fluorouracil—skin cancer	0.000441	0.00111	CcSEcCtD
Salbutamol—Paraesthesia—Temozolomide—skin cancer	0.00044	0.00111	CcSEcCtD
Salbutamol—Dyspnoea—Temozolomide—skin cancer	0.000437	0.0011	CcSEcCtD
Salbutamol—Somnolence—Temozolomide—skin cancer	0.000436	0.0011	CcSEcCtD
Salbutamol—Dyspepsia—Temozolomide—skin cancer	0.000431	0.00109	CcSEcCtD
Salbutamol—Anorexia—Fluorouracil—skin cancer	0.00043	0.00109	CcSEcCtD
Salbutamol—Abdominal pain—Dactinomycin—skin cancer	0.000428	0.00108	CcSEcCtD
Salbutamol—Body temperature increased—Dactinomycin—skin cancer	0.000428	0.00108	CcSEcCtD
Salbutamol—Hypersensitivity—Bleomycin—skin cancer	0.000428	0.00108	CcSEcCtD
Salbutamol—Decreased appetite—Temozolomide—skin cancer	0.000426	0.00107	CcSEcCtD
Salbutamol—Cardiac disorder—Docetaxel—skin cancer	0.000426	0.00107	CcSEcCtD
Salbutamol—Flushing—Docetaxel—skin cancer	0.000426	0.00107	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Temozolomide—skin cancer	0.000423	0.00107	CcSEcCtD
Salbutamol—Fatigue—Temozolomide—skin cancer	0.000422	0.00107	CcSEcCtD
Salbutamol—Hypotension—Fluorouracil—skin cancer	0.000422	0.00106	CcSEcCtD
Salbutamol—Pain—Temozolomide—skin cancer	0.000419	0.00106	CcSEcCtD
Salbutamol—Constipation—Temozolomide—skin cancer	0.000419	0.00106	CcSEcCtD
Salbutamol—Asthenia—Bleomycin—skin cancer	0.000417	0.00105	CcSEcCtD
Salbutamol—Angiopathy—Docetaxel—skin cancer	0.000416	0.00105	CcSEcCtD
Salbutamol—Immune system disorder—Docetaxel—skin cancer	0.000414	0.00104	CcSEcCtD
Salbutamol—Mediastinal disorder—Docetaxel—skin cancer	0.000413	0.00104	CcSEcCtD
Salbutamol—Chills—Docetaxel—skin cancer	0.000411	0.00104	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000411	0.00104	CcSEcCtD
Salbutamol—Pruritus—Bleomycin—skin cancer	0.000411	0.00104	CcSEcCtD
Salbutamol—Arrhythmia—Docetaxel—skin cancer	0.00041	0.00103	CcSEcCtD
Salbutamol—Insomnia—Fluorouracil—skin cancer	0.000408	0.00103	CcSEcCtD
Salbutamol—Paraesthesia—Fluorouracil—skin cancer	0.000405	0.00102	CcSEcCtD
Salbutamol—Feeling abnormal—Temozolomide—skin cancer	0.000404	0.00102	CcSEcCtD
Salbutamol—Dyspnoea—Fluorouracil—skin cancer	0.000402	0.00101	CcSEcCtD
Salbutamol—Mental disorder—Docetaxel—skin cancer	0.000402	0.00101	CcSEcCtD
Salbutamol—Somnolence—Fluorouracil—skin cancer	0.000401	0.00101	CcSEcCtD
Salbutamol—Gastrointestinal pain—Temozolomide—skin cancer	0.000401	0.00101	CcSEcCtD
Salbutamol—Malnutrition—Docetaxel—skin cancer	0.000399	0.00101	CcSEcCtD
Salbutamol—Hypersensitivity—Dactinomycin—skin cancer	0.000399	0.00101	CcSEcCtD
Salbutamol—Dyspepsia—Fluorouracil—skin cancer	0.000397	0.001	CcSEcCtD
Salbutamol—Decreased appetite—Fluorouracil—skin cancer	0.000392	0.00099	CcSEcCtD
Salbutamol—Dysgeusia—Docetaxel—skin cancer	0.000391	0.000986	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00039	0.000983	CcSEcCtD
Salbutamol—Urticaria—Temozolomide—skin cancer	0.000389	0.000981	CcSEcCtD
Salbutamol—Asthenia—Dactinomycin—skin cancer	0.000389	0.00098	CcSEcCtD
Salbutamol—Abdominal pain—Temozolomide—skin cancer	0.000387	0.000977	CcSEcCtD
Salbutamol—Body temperature increased—Temozolomide—skin cancer	0.000387	0.000977	CcSEcCtD
Salbutamol—Back pain—Docetaxel—skin cancer	0.000386	0.000974	CcSEcCtD
Salbutamol—Pain—Fluorouracil—skin cancer	0.000386	0.000973	CcSEcCtD
Salbutamol—Muscle spasms—Docetaxel—skin cancer	0.000384	0.000968	CcSEcCtD
Salbutamol—Feeling abnormal—Fluorouracil—skin cancer	0.000372	0.000938	CcSEcCtD
Salbutamol—Diarrhoea—Dactinomycin—skin cancer	0.000371	0.000935	CcSEcCtD
Salbutamol—Vomiting—Bleomycin—skin cancer	0.000369	0.000931	CcSEcCtD
Salbutamol—Rash—Bleomycin—skin cancer	0.000366	0.000923	CcSEcCtD
Salbutamol—Dermatitis—Bleomycin—skin cancer	0.000366	0.000923	CcSEcCtD
Salbutamol—Hypersensitivity—Temozolomide—skin cancer	0.000361	0.00091	CcSEcCtD
Salbutamol—Urticaria—Fluorouracil—skin cancer	0.000359	0.000904	CcSEcCtD
Salbutamol—Syncope—Docetaxel—skin cancer	0.000358	0.000903	CcSEcCtD
Salbutamol—Body temperature increased—Fluorouracil—skin cancer	0.000357	0.0009	CcSEcCtD
Salbutamol—Palpitations—Docetaxel—skin cancer	0.000353	0.00089	CcSEcCtD
Salbutamol—Asthenia—Temozolomide—skin cancer	0.000352	0.000886	CcSEcCtD
Salbutamol—Loss of consciousness—Docetaxel—skin cancer	0.000351	0.000885	CcSEcCtD
Salbutamol—Cough—Docetaxel—skin cancer	0.000348	0.000878	CcSEcCtD
Salbutamol—Pruritus—Temozolomide—skin cancer	0.000347	0.000874	CcSEcCtD
Salbutamol—Nausea—Bleomycin—skin cancer	0.000345	0.00087	CcSEcCtD
Salbutamol—Hypertension—Docetaxel—skin cancer	0.000345	0.000869	CcSEcCtD
Salbutamol—Vomiting—Dactinomycin—skin cancer	0.000344	0.000868	CcSEcCtD
Salbutamol—Rash—Dactinomycin—skin cancer	0.000342	0.000861	CcSEcCtD
Salbutamol—Arthralgia—Docetaxel—skin cancer	0.00034	0.000857	CcSEcCtD
Salbutamol—Myalgia—Docetaxel—skin cancer	0.00034	0.000857	CcSEcCtD
Salbutamol—Chest pain—Docetaxel—skin cancer	0.00034	0.000857	CcSEcCtD
Salbutamol—Diarrhoea—Temozolomide—skin cancer	0.000335	0.000845	CcSEcCtD
Salbutamol—Hypersensitivity—Fluorouracil—skin cancer	0.000333	0.000839	CcSEcCtD
Salbutamol—Dry mouth—Docetaxel—skin cancer	0.000332	0.000838	CcSEcCtD
Salbutamol—Anaphylactic shock—Docetaxel—skin cancer	0.000326	0.000822	CcSEcCtD
Salbutamol—Oedema—Docetaxel—skin cancer	0.000326	0.000822	CcSEcCtD
Salbutamol—Dizziness—Temozolomide—skin cancer	0.000324	0.000817	CcSEcCtD
Salbutamol—Infection—Docetaxel—skin cancer	0.000324	0.000816	CcSEcCtD
Salbutamol—Nausea—Dactinomycin—skin cancer	0.000322	0.000811	CcSEcCtD
Salbutamol—Shock—Docetaxel—skin cancer	0.000321	0.000808	CcSEcCtD
Salbutamol—Nervous system disorder—Docetaxel—skin cancer	0.00032	0.000806	CcSEcCtD
Salbutamol—Pruritus—Fluorouracil—skin cancer	0.000319	0.000805	CcSEcCtD
Salbutamol—Tachycardia—Docetaxel—skin cancer	0.000318	0.000802	CcSEcCtD
Salbutamol—Skin disorder—Docetaxel—skin cancer	0.000316	0.000798	CcSEcCtD
Salbutamol—Vomiting—Temozolomide—skin cancer	0.000311	0.000786	CcSEcCtD
Salbutamol—Anorexia—Docetaxel—skin cancer	0.000311	0.000783	CcSEcCtD
Salbutamol—Rash—Temozolomide—skin cancer	0.000309	0.000779	CcSEcCtD
Salbutamol—Diarrhoea—Fluorouracil—skin cancer	0.000309	0.000779	CcSEcCtD
Salbutamol—Dermatitis—Temozolomide—skin cancer	0.000309	0.000778	CcSEcCtD
Salbutamol—Headache—Temozolomide—skin cancer	0.000307	0.000774	CcSEcCtD
Salbutamol—Hypotension—Docetaxel—skin cancer	0.000304	0.000768	CcSEcCtD
Salbutamol—Dizziness—Fluorouracil—skin cancer	0.000298	0.000753	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000297	0.000749	CcSEcCtD
Salbutamol—Insomnia—Docetaxel—skin cancer	0.000295	0.000743	CcSEcCtD
Salbutamol—Paraesthesia—Docetaxel—skin cancer	0.000293	0.000738	CcSEcCtD
Salbutamol—Nausea—Temozolomide—skin cancer	0.000291	0.000734	CcSEcCtD
Salbutamol—Dyspnoea—Docetaxel—skin cancer	0.00029	0.000732	CcSEcCtD
Salbutamol—Somnolence—Docetaxel—skin cancer	0.00029	0.00073	CcSEcCtD
Salbutamol—Vomiting—Fluorouracil—skin cancer	0.000287	0.000724	CcSEcCtD
Salbutamol—Dyspepsia—Docetaxel—skin cancer	0.000287	0.000723	CcSEcCtD
Salbutamol—Rash—Fluorouracil—skin cancer	0.000285	0.000718	CcSEcCtD
Salbutamol—Dermatitis—Fluorouracil—skin cancer	0.000284	0.000717	CcSEcCtD
Salbutamol—Decreased appetite—Docetaxel—skin cancer	0.000283	0.000714	CcSEcCtD
Salbutamol—Headache—Fluorouracil—skin cancer	0.000283	0.000713	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Docetaxel—skin cancer	0.000281	0.000709	CcSEcCtD
Salbutamol—Fatigue—Docetaxel—skin cancer	0.000281	0.000708	CcSEcCtD
Salbutamol—Pain—Docetaxel—skin cancer	0.000279	0.000703	CcSEcCtD
Salbutamol—Constipation—Docetaxel—skin cancer	0.000279	0.000703	CcSEcCtD
Salbutamol—Feeling abnormal—Docetaxel—skin cancer	0.000268	0.000677	CcSEcCtD
Salbutamol—Nausea—Fluorouracil—skin cancer	0.000268	0.000676	CcSEcCtD
Salbutamol—Gastrointestinal pain—Docetaxel—skin cancer	0.000266	0.000672	CcSEcCtD
Salbutamol—Abdominal pain—Docetaxel—skin cancer	0.000258	0.000649	CcSEcCtD
Salbutamol—Body temperature increased—Docetaxel—skin cancer	0.000258	0.000649	CcSEcCtD
Salbutamol—Hypersensitivity—Docetaxel—skin cancer	0.00024	0.000605	CcSEcCtD
Salbutamol—Asthenia—Docetaxel—skin cancer	0.000234	0.000589	CcSEcCtD
Salbutamol—Pruritus—Docetaxel—skin cancer	0.000231	0.000581	CcSEcCtD
Salbutamol—Diarrhoea—Docetaxel—skin cancer	0.000223	0.000562	CcSEcCtD
Salbutamol—Dizziness—Docetaxel—skin cancer	0.000215	0.000543	CcSEcCtD
Salbutamol—Vomiting—Docetaxel—skin cancer	0.000207	0.000522	CcSEcCtD
Salbutamol—Rash—Docetaxel—skin cancer	0.000205	0.000518	CcSEcCtD
Salbutamol—Dermatitis—Docetaxel—skin cancer	0.000205	0.000518	CcSEcCtD
Salbutamol—Headache—Docetaxel—skin cancer	0.000204	0.000515	CcSEcCtD
Salbutamol—Nausea—Docetaxel—skin cancer	0.000194	0.000488	CcSEcCtD
